Aurobindo bags one more cephalosporin from USFDA

Aurobindo Pharma Ltd has announced that the Company has received one more approval from USFDA for Cefadroxil capsules 500 mg.

Cefadroxil is a first generation Cephalosporin antibiotic. It is used in a wide variety of bacterial infections (respiratory, skin & soft tissue, and Urinary tract infections).

Cefadroxil is the Company's 37th USFDA approval in total and third approval from its cephalosporin range.

Cefadroxil 500mg capsules commands a market of over US $ 21 million in the USA.

Source : Equity Bulls

Keywords